Financhill
Back

Akari Therapeutics PLC Quote, Financials, Valuation and Earnings

Akari Therapeutics PLC Price Quote

$1.30

Akari Therapeutics PLC Key Stats

Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Day range:
$1.10 - $1.33
52-week range:
$1.08 - $4.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
142.2K
Avg. volume:
37.6K
1-year change:
-56.67%
Market cap:
$32.2M
Revenue:
$0
EPS:
$-2.75

How Much Does Akari Therapeutics PLC Make?

Data Unavailable

Is Akari Therapeutics PLC Growing As A Company?

Data Unavailable

Akari Therapeutics PLC Stock Price Performance

What Is Akari Therapeutics PLC 52-Week High & Low?

Akari Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akari Therapeutics PLC?

Is Akari Therapeutics PLC Cash Flow Positive?

  • What Is AKTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14.8M
  • What Is Akari Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.4M
  • What Is Akari Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Akari Therapeutics PLC Return On Invested Capital

Data Unavailable

Akari Therapeutics PLC Earnings Date & Stock Price

Akari Therapeutics PLC Competitors

Akari Therapeutics PLC Dividend Yield

Akari Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 100%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 80.00
Upside from Last Price: 6053.85%

Major Shareholders

  • How many AKTX shares are owned by institutional investors?
    229.5K AKTX shares are owned by institutional investors
  • How many AKTX shares are owned by insiders?
    5B AKTX shares are owned by insiders